We are live on ! Find out more
BSX.PRA

Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA

Delisted

BSX.PRA was delisted on the 31st of May, 2023.

Back to rankings

1 hedge funds and large institutions have $3.58M invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

1% less capital invested

Capital invested by funds: $3.62M → $3.58M (-$49.6K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
LTI
Laffer Tengler Investments
Tennessee
-$72.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
LTI
1
Laffer Tengler Investments
Tennessee
$3.58M -$72.7K -613 -2%

BSX.PRA Hedge Fund Activity: Q3 2021 in Review

1 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q3 2021, worth a combined $3.58M — down 1.4% from $3.62M a quarter earlier.

Fund positioning in BSX.PRA was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Laffer Tengler Investments, cutting an estimated $72.7K.

  • 1 institutional investor held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $3.58M of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q3 2021, down 1.4% quarter-over-quarter.
  • 0 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q3 2021 and 0 closed out.
  • The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q3 2021 was Laffer Tengler Investments, an estimated $72.7K sold.

Based on aggregated 13F filings for Q3 2021.